Charles River Laboratories
Michel Provence is a seasoned executive with extensive experience in the biopharmaceutical industry, currently serving as Corporate Vice President, Global Accounts and Corporate Vice President of Safety Assessment for Canada and Pennsylvania at Charles River Laboratories since 2004. Over the years, Michel has held multiple leadership roles, including Site Director for Safety Assessment Services and General Manager of Charles River Canada Research Models. Michel also contributed to the advancement of the industry as Chair of the Board and Board Member for BIOQuebec from April 2018 to June 2022. Prior professional experience includes roles as International Project Leader at A+A and Biotech and Biomedical Project Leader at Yole Développement. Michel holds a PhD in Chemistry from Université Claude Bernard Lyon 1, earned between 1990 and 1995.
This person is not in any teams
This person is not in any offices
Charles River Laboratories
15 followers
Charles River Laboratories International, Inc. is an early-stage contract research company. The Company is engaged in laboratory animal medicine and science (research model technologies) and develop a portfolio of discovery and safety assessment services, both good laboratory practice (GLP) and non-GLP, which supports its clients from target identification through non-clinical development. The Company operates in three segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Support (Manufacturing). The RMS segment includes Research Models and Research Model Services. The DSA segment includes Discovery Services and Safety Assessment. The Manufacturing segment includes Microbial Solutions, Avian, Biologics and Contract Manufacturing. The Company also provides a suite of products and services to support the Company's clients' manufacturing activities.